Skip to main content

Table 1 Patient characteristics

From: Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer

 

Group IT (n = 9)

Group SA (n = 6)

Age, median (range)

66 (57–75)

77 (63–90)

Gender

Male

Male

Histological cell type

  

Squamous cell carcinoma

6

1

Adenocarcinoma

3

4

Large cell carcinoma

0

1

Clinical stage

  

1

0

4

2

0

2

3

9

0

T1aN2

1

 

T2bN2

3

 

T3N1

3

 

T3N2

2

 

Pathological stage*

  

0

4

0

1

2

4

2

0

2

3

3

0

T1aN2

1

 

T1bN2

1

 

T3N1

1

 

Pathological effect

  

Complete response

4

-

Major response

4

-

Minor response

1

-

Operative procedure

  

Lobectomy**

6

6

Pneumonectomy

3

0

  1. Abbreviations: IT Induction chemoradiotherapy followed by surgery, SA Surgery alone.
  2. *Pathological stage means post-therapeutic stage (yp–stage) in the IT group.
  3. **Lobectomy, including bilobectomy and lobectomy with bronchoplasty/angioplasty.